Trials / Recruiting
RecruitingNCT06050447
Factors Affecting the Results of Treatment of Patients With Colorectal Cancer
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,200 (estimated)
- Sponsor
- Immanuel Kant Baltic Federal University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study attempts to quantify the relative risks for mortality, anastomotic leakage and other early and late postoperative complications, recurrence rate, cancer-specific survival, recurrence-free survival after colorectal surgery for patients with colorectal cancer depending on the localization of the tumor.
Conditions
- Colorectal Cancer
- Colon Cancer
- Rectal Cancer
- Colorectal Adenocarcinoma
- Colorectal Neoplasms Malignant
- Rectal Adenocarcinoma
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Right hemicolectomy | Resection of the caecum and ascending colon is appropriate for patients with tumors located anywhere from caecum to the transverse colon |
| PROCEDURE | Left hemicolectomy | Resection of the sigmoid colon is appropriate for patients with tumors located anywhere from the distal transverse colon to the rectosigmoid junction. |
| PROCEDURE | Sigmoid colon resection | Resection of the sigmoid colon is appropriate for patients with tumors located in the sigmoid colon |
| PROCEDURE | Anterior resection of the rectum | AR is appropriate for tumors located in rectosigmoid junction and in the proximal rectum |
| PROCEDURE | Low anterior resection of the rectum | LAR is appropriate for tumors located in the middle and low rectum |
| PROCEDURE | Abdominoperineal resection | APR is appropriate for distal rectal cancers that invade the external sphincter or the levator muscles |
| PROCEDURE | Total Colectomy | Total abdominal colectomy may be indicated for patients with primary multiple cancer tumors |
Timeline
- Start date
- 2023-09-01
- Primary completion
- 2024-09-01
- Completion
- 2026-09-01
- First posted
- 2023-09-22
- Last updated
- 2023-09-22
Locations
1 site across 1 country: Russia
Source: ClinicalTrials.gov record NCT06050447. Inclusion in this directory is not an endorsement.